Spots Global Cancer Trial Database for gastrointestinal diseases
Every month we try and update this database with for gastrointestinal diseases cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Drainage After Rectal Excision for Rectal Cancer | NCT01269567 | Rectal Cancer S... Randomized Clin... Multicenter Stu... Pelvic Drainage | Laying and mana... No pelvic drain... | 18 Years - | University Hospital, Bordeaux | |
| Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases | NCT05322486 | Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Neoplasms, Seco... Neoplasm Metast... Digestive Syste... Gastrointestina... Colonic Disease Intestinal Dise... Rectal Diseases | surgery of the ... chemotherapy | 18 Years - | State Scientific Centre of Coloproctology, Russian Federation | |
| Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease | NCT01819766 | Inflammatory Bo... Primary Scleros... Colorectal Neop... Colorectal Canc... | 18 Years - 84 Years | Exact Sciences Corporation | ||
| Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection | NCT04457297 | Colorectal Neop... Trifluridine an... Circulating Tum... | trifluridine an... Placebo | 20 Years - | National Cancer Center Hospital East | |
| Multi-marker Stool Test for Detection of Colorectal Neoplasia: Marker Panel Selection and Technical Development Studies | NCT01260168 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | 40 Years - 90 Years | Exact Sciences Corporation | ||
| Swedish Mammography Cohort | NCT01127698 | Cancers Cardiovascular ... Cataract Gastrointestina... Osteoporosis Fractures | 40 Years - 74 Years | Karolinska Institutet | ||
| Multi-Target Colorectal Cancer Screening Test for the Detection of Colorectal Advanced Adenomatous Polyps and Cancer | NCT01397747 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | 50 Years - 84 Years | Exact Sciences Corporation | ||
| The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients | NCT00247338 | Gastrointestina... Postoperative C... | low calorie, lo... | 18 Years - 80 Years | Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd | |
| Molecular, Pathologic and MRI Investigation of the Prognostic and Redictive Importance of Extramural Venous Invasion in Rectal Cancer (MARVEL) Trial | NCT01995942 | Adenocarcinoma Rectal Diseases Colorectal Neop... Adenocarcinoma,... Carcinoma Neoplasms, Glan... Neoplasms by Hi... Neoplasms Neoplasms, Cyst... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Digestive Syste... Gastrointestina... Intestinal Dise... | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| Adoptive Cell Therapy Plus Chemotherapy and Radiation After Surgery in Treating Patients With Colorectal Cancer | NCT02202928 | Colorectal Canc... Neoplasms Intestinal Neop... Digestive Syste... Gastrointestina... | DC-CIK Radiotherapy Chemotherapy | 18 Years - 80 Years | Shenzhen Hornetcorn Bio-technology Company, LTD | |
| Observational Study of Early Contact With Palliative Care Unit for Patients Receiving First Line Palliative Chemotherapy With Cancer in Upper Gastrointestinal Canal, or Second Line Palliative Chemotherapy in Patients With Colorectal Cancer - an Open, Randomised Investigator Initiated Trial. | NCT02246725 | Tumor in Upper ... | Contact with pa... | 18 Years - | Lund University Hospital | |
| An Extended Feasibility Phase I/II Study of Methylenetetrahydrofolate (Arfolitixorin) and Pemetrexed Single Agent, Given as Neoadjuvant Treatment in Patients With Resectable Rectal Cancer | NCT01397305 | Rectal Cancer | [6R] 5,10-methy... Pemetrexed | 18 Years - | Isofol Medical AB | |
| A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST) | NCT05160168 | Gastrointestina... Neoplasms, Conn... Neoplasms, Conn... Neoplasms by Hi... Neoplasms Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... | THE-630 | 18 Years - | Theseus Pharmaceuticals | |
| SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) | NCT01966289 | Metastatic Colo... | CY GVAX SGI-110 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| SGI-110 in Combination With an Allogeneic Colon Cancer Cell Vaccine (GVAX) and Cyclophosphamide (CY) in Metastatic Colorectal Cancer (mCRC) | NCT01966289 | Metastatic Colo... | CY GVAX SGI-110 | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Advanced Gastrointestinal Endoscopic Imaging | NCT01034670 | Gastrointestina... Gastric (Stomac... Gastrointestina... | Dual axis endos... wide field fluo... CellVizio fluorescent Pep... fluorescein indocyanine gre... | 18 Years - | Stanford University | |
| Cohort of Swedish Men | NCT01127711 | Cancers Cardiovascular ... Cataract Gastrointestina... Osteoporosis Fractures | 45 Years - 79 Years | Karolinska Institutet | ||
| Microbiome Test for the Detection of Colorectal Polyps and Cancer | NCT02141945 | Colorectal Neop... Colorectal Canc... | 45 Years - 80 Years | Metabiomics Corp | ||
| Advanced Gastrointestinal Endoscopic Imaging | NCT01034670 | Gastrointestina... Gastric (Stomac... Gastrointestina... | Dual axis endos... wide field fluo... CellVizio fluorescent Pep... fluorescein indocyanine gre... | 18 Years - | Stanford University | |
| Low Rectal Cancer Study (MERCURY II) | NCT02005965 | Adenocarcinoma Adenocarcinoma,... Carcinoma Neoplasms, Glan... Neoplasms by Hi... Neoplasms Neoplasms, Cyst... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Digestive Syste... Gastrointestina... Intestinal Dise... Rectal Diseases | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | NCT04644315 | Neoplasms Colorectal Neop... Melanoma Pancreatic Neop... Sarcoma Ovarian Neoplas... Brain Neoplasms Thyroid Neoplas... Neuroendocrine ... Cholangiocarcin... Salivary Gland ... Head and Neck N... Thyroid Cancer,... Lymphoma, Large... Neoplasms by Si... Respiratory Tra... Thoracic Neopla... Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Central Nervous... | Alectinib | 18 Years - | Hoffmann-La Roche | |
| Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) | NCT00867113 | Gastrointestina... | imatinib mesyla... | 18 Years - | Novartis | |
| Stool Sample Collection Protocol for Development of Screening Test for Colorectal Cancer and Other Digestive Tract Cancers | NCT02503631 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | Stool Sample Co... | 40 Years - 90 Years | Exact Sciences Corporation | |
| Drainage After Rectal Excision for Rectal Cancer | NCT01269567 | Rectal Cancer S... Randomized Clin... Multicenter Stu... Pelvic Drainage | Laying and mana... No pelvic drain... | 18 Years - | University Hospital, Bordeaux | |
| Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases | NCT05322486 | Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Neoplasms, Seco... Neoplasm Metast... Digestive Syste... Gastrointestina... Colonic Disease Intestinal Dise... Rectal Diseases | surgery of the ... chemotherapy | 18 Years - | State Scientific Centre of Coloproctology, Russian Federation | |
| Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | NCT04080843 | Colorectal Canc... RAS and BRAF Wi... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Rectal Diseases | Anlotinib Hydro... Capecitabine Oxaliplatin | 18 Years - 75 Years | Zhejiang University | |
| Drainage After Rectal Excision for Rectal Cancer | NCT01269567 | Rectal Cancer S... Randomized Clin... Multicenter Stu... Pelvic Drainage | Laying and mana... No pelvic drain... | 18 Years - | University Hospital, Bordeaux | |
| Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer | NCT01294826 | Recurrent Colon... Recurrent Recta... Stage IV Colon ... Stage IV Rectal... Adenocarcinoma ... Adenocarcinoma ... | AUY922 Cetuximab | 18 Years - | Swedish Medical Center | |
| Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer | NCT02322593 | Gastric Cancer | TAS-118 plus Ox... S-1 plus Cispla... | 20 Years - | Taiho Pharmaceutical Co., Ltd. | |
| Intra-arterial Y-90 TheraSpheres for Hepatic Metastases From Solid Tumors | NCT01177007 | Liver Neoplasms | TheraSphere, Yt... | 18 Years - | Yale University | |
| Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients | NCT05252078 | Esophageal Squa... Esophageal Neop... Esophageal Dise... Gastrointestina... Gastrointestina... Digestive Syste... Digestive Syste... Neoplasms by Si... Neoplasms by Hi... Neoplasms, Squa... Carcinoma, Squa... | Anlotinib hydro... TQB2450 | 18 Years - | Jiangxi Provincial Cancer Hospital | |
| Evaluation of Arterial Pressure Based Cardiac Output for Goal-Directed Perioperative Therapy | NCT00526331 | Esophageal Dise... Gastrointestina... Disorder of the... Gynecologic Dis... Kidney Diseases Liver Diseases Pancreatic Dise... Prostate Cancer Spinal Disease | Vigileo Monitor FloTrac Sensor | 18 Years - | M.D. Anderson Cancer Center | |
| A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors | NCT04644315 | Neoplasms Colorectal Neop... Melanoma Pancreatic Neop... Sarcoma Ovarian Neoplas... Brain Neoplasms Thyroid Neoplas... Neuroendocrine ... Cholangiocarcin... Salivary Gland ... Head and Neck N... Thyroid Cancer,... Lymphoma, Large... Neoplasms by Si... Respiratory Tra... Thoracic Neopla... Respiratory Tra... Carcinoma, Bron... Bronchial Neopl... Intestinal Neop... Gastrointestina... Digestive Syste... Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Central Nervous... | Alectinib | 18 Years - | Hoffmann-La Roche | |
| Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer | NCT00838578 | Colorectal Canc... | KRN330 Irinotecan | 18 Years - | Kyowa Kirin Co., Ltd. | |
| Docetaxel, 5-Fluorouracil and Oxaliplatin in Adenocarcinoma of the Stomach or Gastroesophageal Junction Patients | NCT00526110 | Gastrointestina... | 5-Fluorouracil Docetaxel Oxaliplatin | 18 Years - | M.D. Anderson Cancer Center | |
| The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients | NCT00247338 | Gastrointestina... Postoperative C... | low calorie, lo... | 18 Years - 80 Years | Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd | |
| Phase III Study of TAS-118 Plus Oxaliplatin Versus S-1 Plus Cisplatin in Patients With Advanced Gastric Cancer | NCT02322593 | Gastric Cancer | TAS-118 plus Ox... S-1 plus Cispla... | 20 Years - | Taiho Pharmaceutical Co., Ltd. | |
| XELOX Combined With Anlotinib and Penpulimab vs XELOX as Adjuvant Therapy in ctDNA Positive Gastric and Esophagogastric Junction Adenocarcinoma | NCT05494060 | Carcinoma Gastrointestina... Stomach Cancer Gastroesophagea... Digestive Syste... Gastric Cancer Gastrointestina... | Anlotinib hydro... Penpulimab Inje... XELOX | 18 Years - 75 Years | The First Affiliated Hospital with Nanjing Medical University | |
| A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials | NCT05655494 | Cancer | Stand-alone Res... Portal with Vir... | 18 Years - 100 Years | University of Florida | |
| Radiomics for Prediction of Lymph Node Metastasis in Gastric Cancer（RPLNM）(GIPMCS-1701) | NCT03488446 | Digestive Syste... Gastrointestina... Digestive Syste... Gastrointestina... Stomach Neoplas... | 18 Years - | Nanfang Hospital, Southern Medical University | ||
| Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA | NCT01550510 | Stage IV Colore... | Ascorbic Acid Irinotecan | 18 Years - | Thomas Jefferson University | |
| Study of Autologous Tumor Lysate-pulsed D-CIK Combined With Chemotherapy for Gastric Cancer | NCT02215837 | Gastric Cancer Neoplasms Gastrointestina... Digestive Syste... Gastrointestina... | Chemotherapy Ag-D-CIK | 18 Years - 80 Years | Shenzhen Hornetcorn Bio-technology Company, LTD | |
| A Study of Encorafenib Plus Cetuximab With or Without Chemotherapy in People With Previously Untreated Metastatic Colorectal Cancer | NCT04607421 | Neoplasms | Encorafenib Cetuximab Oxaliplatin Irinotecan Leucovorin 5-FU Capecitabine Bevacizumab | 16 Years - | Pfizer | |
| Study to Evaluate the Efficacy and Safety of Three Different Doses of SCV 07 in Attenuating Oral Mucositis in Subjects With Head and Neck Cancer | NCT01247246 | Oral Mucositis | SCV-07 Placebo | 18 Years - | SciClone Pharmaceuticals | |
| The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking Aspirin | NCT01549418 | Gastrointestina... | Aspirin (ASA) Placebo | 40 Years - | Maria Sklodowska-Curie National Research Institute of Oncology | |
| Evaluate the Efficacy of Adding Intraluminal Brachytherapy After CCRT for Local-regional Thoracic Esophageal Cancer. | NCT06365866 | Esophageal Neop... Head and Neck N... Gastrointestina... Digestive Syste... Digestive Syste... Esophageal Dise... Neoplasms by Si... Gastrointestina... Neoplasms | "BRAXX" Esophag... Add-on of intra... | 20 Years - 85 Years | Taipei Veterans General Hospital, Taiwan | |
| Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease | NCT01819766 | Inflammatory Bo... Primary Scleros... Colorectal Neop... Colorectal Canc... | 18 Years - 84 Years | Exact Sciences Corporation | ||
| Low Rectal Cancer Study (MERCURY II) | NCT02005965 | Adenocarcinoma Adenocarcinoma,... Carcinoma Neoplasms, Glan... Neoplasms by Hi... Neoplasms Neoplasms, Cyst... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Digestive Syste... Gastrointestina... Intestinal Dise... Rectal Diseases | 18 Years - | Royal Marsden NHS Foundation Trust | ||
| Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer | NCT01294826 | Recurrent Colon... Recurrent Recta... Stage IV Colon ... Stage IV Rectal... Adenocarcinoma ... Adenocarcinoma ... | AUY922 Cetuximab | 18 Years - | Swedish Medical Center | |
| Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers | NCT03122548 | Gastric Adenoca... Gastroesophagea... Esophageal Aden... | CRS-207 Pembrolizumab | 18 Years - | Aduro Biotech, Inc. | |
| The Impact of Low Calorie and Low Nitrogen Parenteral Nutrition Support on the Clinical Outcome of Postoperative Patients | NCT00247338 | Gastrointestina... Postoperative C... | low calorie, lo... | 18 Years - 80 Years | Fresenius Kabi Sino-Swed Pharmaceutical Corp. Ltd | |
| Initial Attack on Latent Metastasis Using TAS-102 for ct DNA Identified Colorectal Cancer Patients After Curative Resection | NCT04457297 | Colorectal Neop... Trifluridine an... Circulating Tum... | trifluridine an... Placebo | 20 Years - | National Cancer Center Hospital East | |
| Exact CRC Screening Test: Stool Sample Collection Study to Support Assay Validation Testing | NCT01600209 | Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | 50 Years - 84 Years | Exact Sciences Corporation | ||
| Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness | NCT01816607 | Rectal Diseases Rectal Neoplasm... Gastrointestina... Gastrointestina... | new functional ... | 18 Years - | University Hospital, Akershus | |
| Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type mCRC Patients | NCT04080843 | Colorectal Canc... RAS and BRAF Wi... Colorectal Neop... Intestinal Neop... Gastrointestina... Digestive Syste... Neoplasms by Si... Neoplasms Digestive Syste... Gastrointestina... Colonic Disease... Intestinal Dise... Rectal Diseases | Anlotinib Hydro... Capecitabine Oxaliplatin | 18 Years - 75 Years | Zhejiang University | |
| Study of AUY922 and Cetuximab in Patients With KRAS Wild-Type Metastatic Colorectal Cancer | NCT01294826 | Recurrent Colon... Recurrent Recta... Stage IV Colon ... Stage IV Rectal... Adenocarcinoma ... Adenocarcinoma ... | AUY922 Cetuximab | 18 Years - | Swedish Medical Center | |
| Evolution® Biliary Stent System Clinical Study | NCT01962168 | Biliary Tract N... Neoplasms Gastrointestina... Digestive Syste... Biliary Tract Stents | Evolution® Bili... | 18 Years - | Cook Group Incorporated | |
| A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer | NCT02753127 | Colorectal Canc... | Napabucasin Fluorouracil Leucovorin Irinotecan Bevacizumab | 18 Years - | Sumitomo Pharma America, Inc. | |
| Optimizing the Preparation Regime Prior to Colonoscopy Procedure With Pure-Vu System | NCT03493009 | Gastrointestina... Colorectal Canc... | Pure-Vu System | 22 Years - 75 Years | Motus GI Medical Technologies Ltd | |
| Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) | NCT02503696 | Inflammatory Bo... Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | Stool Collectio... | 18 Years - 84 Years | Exact Sciences Corporation | |
| Safety and Efficacy of CRS-207 With Pembrolizumab in Gastric, Gastroesophageal Junction or Esophageal Cancers | NCT03122548 | Gastric Adenoca... Gastroesophagea... Esophageal Aden... | CRS-207 Pembrolizumab | 18 Years - | Aduro Biotech, Inc. | |
| Point of Care 3D Ultrasound for Various Applications: A Pilot Study | NCT02831556 | Appendicitis Evidence of Cho... Gallstones Pregnancy, Ecto... Aortic Aneurysm Kidney Stones Intrauterine Pr... Diverticulitis Abdominal Injur... Tumors Pancreatitis Digestive Syste... Gastrointestina... Intraabdominal ... Intestinal Dise... Pregnancy Vascular Diseas... Uterine Fibroid... Ovarian Cysts Uterine Abnomin... Bladder Abnomin... Testicular Abno... Polyps | - | Duke University | ||
| Sample Collection Study to Evaluate DNA Markers in Subjects With Inflammatory Bowel Disease (IBD) | NCT02503696 | Inflammatory Bo... Colorectal Neop... Digestive Syste... Colonic Disease... Colorectal Canc... | Stool Collectio... | 18 Years - 84 Years | Exact Sciences Corporation | |
| Five Year Adjuvant Imatinib Mesylate (Gleevec®) in Gastrointestinal Stromal Tumor (GIST) | NCT00867113 | Gastrointestina... | imatinib mesyla... | 18 Years - | Novartis | |
| Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis | NCT00035334 | Secondary (AA) ... Rheumatoid Arth... Nephrotic Syndr... Familial Medite... Kidney Diseases Gastrointestina... | NC-503 (Anti-am... | 18 Years - | Bellus Health Inc. - a GSK company | |
| Research Study of IV Vitamin C in Combination With Irinotecan vs Irinotecan Alone for Advanced Colorectal CA | NCT01550510 | Stage IV Colore... | Ascorbic Acid Irinotecan | 18 Years - | Thomas Jefferson University |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
